Luxtera Completes $22M Series C Investment

Carlsbad, Calif., March 15, 2006 — Luxtera, Inc., a fabless semiconductor company and the world leader in silicon photonics, announced today that the company has closed a $22 million Series C investment from a mix of new corporate sources and returning investors. Returning investors include New Enterprise Associates, Sevin Rosen Funds, August Capital, and Freescale Semiconductor.

“We are delighted to welcome our new investors and appreciate the continued enthusiasm of our returning investors,” said Alex Dickinson, Co-founder, President, & CEO of Luxtera, Inc. “We will use these additional funds to accelerate our product launch, to move into volume production, and to extend our technology leadership in CMOS photonics.”

“We believe that Luxtera has a significant lead in the important field of CMOS silicon photonics and has demonstrated its ability to produce leading-edge products,” said Sumit Sadana, senior vice president of strategy, business development and acting CTO at Freescale Semiconductor. “We are pleased to be both a technology partner and investor in Luxtera.”

Press Contact:
Catriona Harris
PR@vantage for Luxtera
407-767-0527
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
www.pr-vantage.com

About Luxtera Inc.
Luxtera, Inc., a fabless semiconductor company and the world leader in silicon photonics is focused on fulfilling the insatiable demand for bandwidth by uniting the benefits of optical communication technology with the low-cost, high-volume advantages of CMOS fabrication. Luxtera was founded in 2001 by a team of industry-renown researchers and technology managers drawn from the communication and semiconductors industries. Luxtera is funded by leading venture capitalists and has partnerships with a number of the leading computer and communications companies. Luxtera will sample the world’s first CMOS photonics products in Q2 2006 and ship them in Q1 2007. Luxtera is headquartered in Carlsbad, CA. More information on Luxtera can be found on the company's web site: www.luxtera.com.

 PDF download of this Press Release (and others) available here.